ZBH — Zimmer Biomet Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $20.08bn
- $25.77bn
- $7.68bn
- 83
- 45
- 74
- 75
Annual cashflow statement for Zimmer Biomet Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.2 | 446 | 291 | 1,025 | 905 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 706 | 352 | 443 | 97.3 | 101 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -430 | -134 | -311 | -396 | -455 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 1,205 | 1,499 | 1,285 | 1,582 | 1,499 |
| Capital Expenditures | -371 | -417 | -446 | -689 | -597 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -243 | -86.4 | -83 | -89.7 | -291 |
| Acquisition of Business | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -614 | -504 | -529 | -779 | -888 |
| Financing Cash Flow Items | -100 | -173 | 466 | -26.1 | -38.9 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -422 | -1,306 | -844 | -764 | -485 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 184 | -324 | -103 | 40.1 | 110 |